tiprankstipranks

Samarth Kulkarni Insider Profile

18 Followers
Samarth Kulkarni, CEO, Director at Crispr Therapeutics AG, holds 282.16K shares in Crispr Therapeutics AG (Ticker: CRSP), holds ― shares in Black Diamond Therapeutics (Ticker: BDTX), holds ― shares in Repare Therapeutics (Ticker: RPTX).
tipranks
Samarth Kulkarni

Samarth Kulkarni
Crispr Therapeutics AG (CRSP)
CEO, Director

Not Ranked
Samarth Kulkarni has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$13M
100.00%
0.00%
0.00%
0.00%
A breakdown of Samarth Kulkarni's holdings

Insider Roles

Crispr Therapeutics AG
(CRSP)
CEO, Director
Black Diamond Therapeutics
(BDTX)
Director
Repare Therapeutics
(RPTX)
Director
Centessa Pharmaceuticals
(CNTA)
Director
Roles that Samarth Kulkarni holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Samarth Kulkarni

Samarth Kulkarni's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Crispr Therapeutics AG
Nov 13, 2024
CEO, Director
Uninformative Sell
1.67M
$13.33M
Black Diamond Therapeutics
Director
Repare Therapeutics
Director
Centessa Pharmaceuticals
Director
List of latest transactions for each holding click on a transaction to see Samarth Kulkarni's performance on stock

Samarth Kulkarni insider profile FAQ

What is the percentage of profitable transactions made by Samarth Kulkarni?
The percentage of profitable transactions made by Samarth Kulkarni is ―.
    What is the average return per transaction made by Samarth Kulkarni?
    The average return per transaction made by Samarth Kulkarni is ―.
      What stocks does Samarth Kulkarni hold?
      Samarth Kulkarni holds: CRSP, BDTX, RPTX, CNTA stocks.
        What was Samarth Kulkarni’s latest transaction?
        Samarth Kulkarni latest transaction was an Uninformative Sell of $1.67M.
          What was Samarth Kulkarni's most profitable transaction?
          Samarth Kulkarni’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Samarth Kulkarni's role in Crispr Therapeutics AG?
            Samarth Kulkarni's role in Crispr Therapeutics AG is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.